|
1
|
González-Llorente L, Santacatterina F,
García-Aguilar A, Nuevo-Tapioles C, González-García S, Tirpakova Z,
Toribio ML and Cuezva JM: Overexpression of Mitochondrial IF1
Prevents Metastatic Disease of Colorectal Cancer by Enhancing
Anoikis and Tumor Infiltration of NK Cells. Cancers (Basel).
12:122019. View Article : Google Scholar
|
|
2
|
Khelwatty SA, Essapen S, Bagwan I, Green
M, Seddon AM and Modjtahedi H: Co-expression and prognostic
significance of putative CSC markers CD44, CD133, wild-type EGFR
and EGFRvIII in metastatic colorectal cancer. Oncotarget.
10:1704–1715. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goldstein DA, Zeichner SB, Bartnik CM,
Neustadter E and Flowers CR: Metastatic Colorectal Cancer: A
Systematic Review of the Value of Current Therapies. Clin
Colorectal Cancer. 15:1–6. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu X, Zhang C, Xia Y and Yu J: Over
expression of METRN predicts poor clinical prognosis in colorectal
cancer. Mol Genet Genomic Med. 8:e11022020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Issa IA and Noureddine M: Colorectal
cancer screening: An updated review of the available options. World
J Gastroenterol. 23:5086–5096. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Allemani C, Matsuda T, Di Carlo V,
Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ,
Estève J, et al CONCORD Working Group, : Global surveillance of
trends in cancer survival 2000–14 (CONCORD-3): Analysis of
individual records for 37 513 025 patients diagnosed with one of 18
cancers from 322 population-based registries in 71 countries.
Lancet. 391:1023–1075. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pessaux P, Chenard MP, Bachellier P and
Jaeck D: Consequences of chemotherapy on resection of colorectal
liver metastases. J Visc Surg. 147:e193–e201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lima PMA, Torres LC, Martins MR, da Matta
MC, Lima JTO, de Mello MJG, da Silva LM, Cintra EB Jr, Lira CCR, da
Fonte EJA, et al: Soluble levels of sCD40L and s4-1BB are
associated with a poor prognosis in elderly patients with
colorectal cancer. J Surg Oncol. 121:901–905. 2020.PubMed/NCBI
|
|
13
|
Leiphrakpam PD, Lazenby AJ, Chowdhury S,
Smith LM, Mathiesen M, Brattain MG, Wang J, Black JD and Are C:
Prognostic and therapeutic implications of NHERF1 expression and
regulation in colorectal cancer. J Surg Oncol. 121:547–560. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Keremu A, Maimaiti X, Aimaiti A, Yushan M,
Alike Y, Yilihamu Y and Yusufu A: NRSN2 promotes osteosarcoma cell
proliferation and growth through PI3K/Akt/MTOR and Wnt/β-catenin
signaling. Am J Cancer Res. 7:565–573. 2017.PubMed/NCBI
|
|
15
|
Tang W, Ren A, Xiao H, Sun H and Li B:
Highly expressed NRSN2 is related to malignant phenotype in ovarian
cancer. Biomed Pharmacother. 85:248–255. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang XY, Kuang JL, Yan CS, Tu XY, Zhao
JH, Cheng XS and Ye XQ: NRSN2 promotes non-small cell lung cancer
cell growth through PI3K/Akt/mTOR pathway. Int J Clin Exp Pathol.
8:2574–2581. 2015.PubMed/NCBI
|
|
17
|
Wang X, Han L, Zhang J and Xia Q:
Down-Regulated NRSN2 Promotes Cell Proliferation and Survival
Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma. Dig Dis
Sci. 60:3011–3018. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Björklund M and Koivunen E:
Gelatinase-mediated migration and invasion of cancer cells. Biochim
Biophys Acta. 1755:37–69. 2005.PubMed/NCBI
|
|
20
|
Li W, Xu Y, Wang X, Cao G, Bu W, Wang X,
Fang Z, Xu Y, Dong M and Tao Q: circCCT3 Modulates Vascular
Endothelial Growth Factor A and Wnt Signaling to Enhance Colorectal
Cancer Metastasis Through Sponging miR-613. DNA Cell Biol.
39:118–125. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu G, Lin C, Cheng Z, Wang Q, Hoffman RM,
Singh SR, Huang Y, Zheng W, Yang S and Ye J: TRAF6-Mediated
Inflammatory Cytokines Secretion in LPS-induced Colorectal Cancer
Cells Is Regulated by miR-140. Cancer Genomics Proteomics.
17:23–33. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang XJ, Yu Q, Chi P, Lin HM, Lu XR, Huang
Y, Xu ZB, Huang SH, Sun YW and Ye DX: Identification of gene
biomarkers to predict responses to neoadjuvant chemoradiotherapy in
patients with rectal cancer and pathways enrichment analysis.
Zhonghua Wei Chang Wai Ke Za Zhi. 22:1183–1187. 2019.(In Chinese).
PubMed/NCBI
|
|
23
|
Dziki Ł, Puła A, Stawiski K, Mudza B,
Włodarczyk M and Dziki A: Patients' Awareness Of The Prevention And
Treatment Of Colorectal Cancer. Pol Przegl Chir. 87:459–463. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huerta S, Harris DM, Jazirehi A, Bonavida
B, Elashoff D, Livingston EH and Heber D: Gene expression profile
of metastatic colon cancer cells resistant to cisplatin-induced
apoptosis. Int J Oncol. 22:663–670. 2003.PubMed/NCBI
|
|
25
|
26. Melcher R, Steinlein C, Feichtinger W,
Müller CR, Menzel T, Lührs H, Scheppach W and Schmid M: Spectral
karyotyping of the human colon cancer cell lines SW480 and SW620.
Cytogenet Cell Genet. 88:145–152. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Broznić D, Ratkaj I, Malenica Staver M,
Kraljević Pavelić S, Žurga P, Bubalo D and Gobin I: Evaluation of
the Antioxidant Capacity, Antimicrobial and Antiproliferative
Potential of Fir (Abies alba Mill.) Honeydew Honey Collected
from Gorski kotar (Croatia). Food Technol Biotechnol. 56:533–545.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Selga E, Noé V and Ciudad CJ:
Transcriptional regulation of aldo-keto reductase 1C1 in HT29 human
colon cancer cells resistant to methotrexate: Role in the cell
cycle and apoptosis. Biochem Pharmacol. 75:414–426. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen Z, Xiao K, Chen S, Huang Z, Ye Y and
Chen T: CircRNA hsa_circ_001895 serves as a sponge of miR-296-5p to
promote cell carcinoma progression via regulating SOX12. Cancer
Sci. 111:713–726. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du F, Feng W, Chen S, Wu S, Cao T, Yuan T,
Tian D, Nie Y, Wu K, Fan D, et al: Sex determining region Y-box 12
(SOX12) promotes gastric cancer metastasis by upregulating MMP7 and
IGF1. Cancer Lett. 452:103–118. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du F, Chen J, Liu H, Cai Y, Cao T, Han W,
Yi X, Qian M, Tian D, Nie Y, et al: SOX12 promotes colorectal
cancer cell proliferation and metastasis by regulating asparagine
synthesis. Cell Death Dis. 10:2392019. View Article : Google Scholar : PubMed/NCBI
|
